Erick Gamelin Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 16.5K

2.77% 3M change

9.22% 12M change

Total Value Held N/A

Erick Gamelin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	SELL Payment of exercise price or tax liability	$2,541 $5.42 p/Share	469 Reduced 2.77%	16,492 Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$3,183 $7.92 p/Share	402 Reduced 2.32%	16,961 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$2,822 $7.02 p/Share	402 Reduced 2.26%	17,363 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$3,360 $8.36 p/Share	402 Reduced 2.21%	17,765 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$1,591 $3.4 p/Share	468 Reduced 2.51%	18,167 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$7,086 $5.08 p/Share	1,395 Reduced 6.96%	18,635 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	-	20,030 Added 50.0%	20,030 Common Stock

Chief Development Officer

Watertown, MA

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

Receive news related to Acrivon Therapeutics, Inc.